MF
Elite in Acromegaly

Dr. Maria Fleseriu

OHSU Primary Care Clinic At South Waterfront
Portland, OR
Elite
 in Acromegaly
Specialties:Endocrinology
Experience:30 Years
Clinical Trials:Currently Recruiting for 1 Trial
Accepts:New PatientsMedicare
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Maria Fleseriu's experience treating your condition:
About Dr. Maria Fleseriu

Maria Fleseriu is an Endocrinologist in Portland, Oregon. Dr. Fleseriu has been practicing medicine for over 30 years and is rated as an Elite doctor by MediFind in the treatment of Acromegaly. She is also highly rated in 24 other conditions, according to our data. Her top areas of expertise are Acromegaly, Cushing's disease, Pituitary Tumor, Cushing's syndrome, and Hormone Replacement Therapy (HRT). Dr. Fleseriu is currently accepting new patients.

Her clinical research consists of co-authoring 191 peer reviewed articles and participating in 8 clinical trials in the past 15 years. In particular, she has co-authored 63 articles in the study of Acromegaly.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Maria Fleseriu it is best to call her office and ask if your insurance is accepted.

Accepts Medicare
Call to see if your plan is accepted.
Locations
3303 Sw Bond Ave, Portland, OR 97239
Background & Education
Graduate Institution
Other, 1993
Specialties
Endocrinology
Licenses
Internal Medicine in OR
Hospital Affiliations
Samaritan Albany General Hospital
Mid-Columbia Medical Center
St Charles Redmond
Sky Lakes Medical Center
Good Samaritan Regional Medical Center
OHSU Hospital - Portland
Providence Hood River Memorial Hospital
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
Enrollment Status: Recruiting
Publish Date: January 27, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: November 08, 2022
Intervention Type: Drug
Study Phase: Phase 3
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
Enrollment Status: Active, not recruiting
Publish Date: May 06, 2022
Intervention Type: Drug
Study Drug: Osilodrostat
Study Phase: Phase 2
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: November 01, 2021
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Active, not recruiting
Publish Date: August 03, 2021
Intervention Type: Drug
Study Drug: Levoketoconazole
Study Phase: Phase 3
An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: April 19, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ATR-101 for the Treatment of Cushing's Syndrome
Enrollment Status: Terminated
Publish Date: March 02, 2021
Intervention Type: Drug
Study Phase: Phase 2
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: January 06, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials -
191 Total Publications
Pituitary and SARS CoV-2: An unremitting conundrum.
Journal: Best practice & research. Clinical endocrinology & metabolism
Published: March 06, 2023
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
EV
Dr. Elena V. Varlamov
Endocrinology
Distinguished
Highly rated in
21
conditions
Endocrinology

OHSU

OHSU Harold Schnitzer Diabetes Health Center And Endocrinology Clinic, Marquam Hill

3270 Sw Pavilion Loop, 
Portland, OR 
 0.7 mi

Elena Varlamov is an Endocrinologist in Portland, Oregon. Dr. Varlamov has been practicing medicine for over 14 years and is rated as a Distinguished doctor by MediFind in the treatment of Acromegaly. She is also highly rated in 21 other conditions, according to our data. Her top areas of expertise are Pituitary Tumor, Prolactinoma, Acromegaly, and Hypothalamic Tumor. Dr. Varlamov is currently accepting new patients.

SS
Dr. Sarah C. Soltman
Endocrinology
Experienced
Highly rated in
0
conditions
Endocrinology

OHSU

OHSU Harold Schnitzer Diabetes Health Center And Endocrinology Clinic, Marquam Hill

3270 Sw Pavilion Loop, 
Portland, OR 
 0.7 mi

Sarah Soltman is an Endocrinologist in Portland, Oregon. Dr. Soltman has been practicing medicine for over 12 years and is rated as an Experienced doctor by MediFind in the treatment of Acromegaly. Her top areas of expertise are Acromegaly, Gigantism, Sotos Syndrome, and Hirsutism in Women. Dr. Soltman is currently accepting new patients.

JN
Dr. James L. Neifing
Endocrinology
Experienced
Highly rated in
2
conditions
Endocrinology

Legacy Health

Portland Diabetes Center - SW Barnes

9135 Sw Barnes Rd, 
Portland, OR 
 4.9 mi

James Neifing is an Endocrinologist in Portland, Oregon. Dr. Neifing has been practicing medicine for over 37 years and is rated as an Advanced doctor by MediFind in the treatment of Acromegaly. He is also highly rated in 2 other conditions, according to our data. His top areas of expertise are Osteoporosis, Type 1 Diabetes (T1D), Obesity in Children, and Type 2 Diabetes (T2D). Dr. Neifing is currently accepting new patients.